Contact
Please use this form to send email to PR contact of this press release:
Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDA
TO:
Please use this form to send email to PR contact of this press release:
Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDA
TO: